Paclitaxel and curcumin coadministration in novel cationic PEGylated niosomal formulations exhibit enhanced synergistic antitumor efficacy
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1477-3155
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Paclitaxel and curcumin coadministration in novel cationic PEGylated niosomal formulations exhibit enhanced synergistic antitumor efficacy ; volume:16 ; number:1 ; day:23 ; month:3 ; year:2018 ; pages:1-20 ; date:12.2018
Journal of nanobiotechnology ; 16, Heft 1 (23.3.2018), 1-20, 12.2018
- Urheber
-
Alemi, Ashraf
- Beteiligte Personen und Organisationen
-
Zavar Reza, Javad
Haghiralsadat, Fateme
Zarei Jaliani, Hossein
Haghi Karamallah, Mojtaba
Hosseini, Seyed Ahmad
Haghi Karamallah, Somayeh
SpringerLink (Online service)
- DOI
-
10.1186/s12951-018-0351-4
- URN
-
urn:nbn:de:1111-201805278164
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:38 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Alemi, Ashraf
- Zavar Reza, Javad
- Haghiralsadat, Fateme
- Zarei Jaliani, Hossein
- Haghi Karamallah, Mojtaba
- Hosseini, Seyed Ahmad
- Haghi Karamallah, Somayeh
- SpringerLink (Online service)
Ähnliche Objekte (12)
Synergistic co-administration of docetaxel and curcumin to chemoresistant cancer cells using PEGylated and RIPL peptide-conjugated nanostructured lipid carriers
Cationic PEGylated polycaprolactone nanoparticles carrying post-operation docetaxel for glioma treatment
Passively Targeted Curcumin‐Loaded PEGylated PLGA Nanocapsules for Colon Cancer Therapy In Vivo
PEGylated versus non-PEGylated magnetic nanoparticles as camptothecin delivery system
Promising PEGylated cationic dendrimers for delivery of miRNAs as a possible therapy against HIV-1 infection
PEGylated recombinant human hyaluronidase (PEGPH20) pre-treatment improves intra-tumour distribution and efficacy of paclitaxel in preclinical models
Elevated alpha1-acid glycoprotein in gastric cancer patients inhibits the anticancer effects of paclitaxel, effects restored by co-administration of erythromycin
Observation of antitumor mechanism of GE11-modified paclitaxel and curcumin liposomes based on cellular morphology changes
Safety evaluation of PEGylated MNPs and p-PEGylated MNPs in SD rats
Efficient Delivery of Gold Nanoparticles and miRNA-33a Via Cationic PEGylated Niosomal Formulation to MCF-7 Breast Cancer Cells
Co-delivery of paclitaxel and curcumin to foliate positive cancer cells using Pluronic-coated iron oxide nanoparticles
Phase 2 study of canfosfamide in combination with pegylated liposomal doxorubicin in platinum and paclitaxel refractory or resistant epithelial ovarian cancer
Synergistic co-administration of docetaxel and curcumin to chemoresistant cancer cells using PEGylated and RIPL peptide-conjugated nanostructured lipid carriers
Cationic PEGylated polycaprolactone nanoparticles carrying post-operation docetaxel for glioma treatment
Passively Targeted Curcumin‐Loaded PEGylated PLGA Nanocapsules for Colon Cancer Therapy In Vivo
PEGylated versus non-PEGylated magnetic nanoparticles as camptothecin delivery system
Promising PEGylated cationic dendrimers for delivery of miRNAs as a possible therapy against HIV-1 infection
PEGylated recombinant human hyaluronidase (PEGPH20) pre-treatment improves intra-tumour distribution and efficacy of paclitaxel in preclinical models
Elevated alpha1-acid glycoprotein in gastric cancer patients inhibits the anticancer effects of paclitaxel, effects restored by co-administration of erythromycin
Observation of antitumor mechanism of GE11-modified paclitaxel and curcumin liposomes based on cellular morphology changes
Safety evaluation of PEGylated MNPs and p-PEGylated MNPs in SD rats
Efficient Delivery of Gold Nanoparticles and miRNA-33a Via Cationic PEGylated Niosomal Formulation to MCF-7 Breast Cancer Cells
Co-delivery of paclitaxel and curcumin to foliate positive cancer cells using Pluronic-coated iron oxide nanoparticles
Phase 2 study of canfosfamide in combination with pegylated liposomal doxorubicin in platinum and paclitaxel refractory or resistant epithelial ovarian cancer
Synergistic co-administration of docetaxel and curcumin to chemoresistant cancer cells using PEGylated and RIPL peptide-conjugated nanostructured lipid carriers
Cationic PEGylated polycaprolactone nanoparticles carrying post-operation docetaxel for glioma treatment
Passively Targeted Curcumin‐Loaded PEGylated PLGA Nanocapsules for Colon Cancer Therapy In Vivo
PEGylated versus non-PEGylated magnetic nanoparticles as camptothecin delivery system
Promising PEGylated cationic dendrimers for delivery of miRNAs as a possible therapy against HIV-1 infection
PEGylated recombinant human hyaluronidase (PEGPH20) pre-treatment improves intra-tumour distribution and efficacy of paclitaxel in preclinical models
Elevated alpha1-acid glycoprotein in gastric cancer patients inhibits the anticancer effects of paclitaxel, effects restored by co-administration of erythromycin
Observation of antitumor mechanism of GE11-modified paclitaxel and curcumin liposomes based on cellular morphology changes
Safety evaluation of PEGylated MNPs and p-PEGylated MNPs in SD rats
Efficient Delivery of Gold Nanoparticles and miRNA-33a Via Cationic PEGylated Niosomal Formulation to MCF-7 Breast Cancer Cells
Co-delivery of paclitaxel and curcumin to foliate positive cancer cells using Pluronic-coated iron oxide nanoparticles